B. DOGAN Et Al. , "Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.," Clinical endocrinology , vol.82, pp.422-8, 2015
DOGAN, B. Et Al. 2015. Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.. Clinical endocrinology , vol.82 , 422-8.
DOGAN, B., Karakılıç, E., TUNA, M. Ç., ARDUC, A., BERKER, D., & GULER, S., (2015). Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.. Clinical endocrinology , vol.82, 422-8.
DOGAN, BEKİR Et Al. "Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.," Clinical endocrinology , vol.82, 422-8, 2015
DOGAN, BEKİR Et Al. "Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.." Clinical endocrinology , vol.82, pp.422-8, 2015
DOGAN, B. Et Al. (2015) . "Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.." Clinical endocrinology , vol.82, pp.422-8.
@article{article, author={BEKİR DOĞAN Et Al. }, title={Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.}, journal={Clinical endocrinology}, year=2015, pages={422-8} }